Covid-19 vaccine developer Novavax, one of the stars of the early pandemic, issued a going concern warning which sent its stock reeling. It warned that “substantial doubt exists regarding our abilit
Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss Novavax's “substantial doubts” about the future as the company posted a wide fourth-quarter earnings miss.

NVAX Stock Alert: Is Novavax Going Bankrupt?

10:03am, Wednesday, 01'st Mar 2023
Shares of Novavax (NASDAQ: NVAX ) are down 27% today after the Covid-19 vaccine maker raised doubts about its ability to continue operations. Prior to today, NVAX stock had declined 89% over the past
Novavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with earnings and revenues both missing the Zacks Consensus Estimate. Stock plunges 26.1% in response to

Why Is Novavax (NVAX) Stock Down 26% Today?

08:38am, Wednesday, 01'st Mar 2023
Novavax (NASDAQ: NVAX ) stock is dropping on Wednesday after the vaccine company warned investors about the state of its business. In its latest earnings report, Novavax included a few concerns that i
Novavax shares sank after the COVID-19 vaccine maker warned it has "substantial doubt" about its ability to stay in business through next year.
Novavax (NVAX) delivered earnings and revenue surprises of -147.83% and 5.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Shares of the pharmaceutical company have slipped below $7 after trading well above $300 at points in 2021.
A couple of high-profile companies posted big declines in after-hours trading on Tuesday.
Yahoo Finance Live's Seana Smith examines several stocks trending in the after-hours trading session
CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Novavax's warning that it may not be able to continue as a company. Also, Sarepta shares rise on FDA signaling no advisory meeting on gen

Novavax Doubtful About Its Financial Future

05:11pm, Tuesday, 28'th Feb 2023
Novavax Inc. said there's substantial doubt about its ability to stay in business through next year, underscoring the depth of the drugmaker's struggle to develop and sell a Covid-19 vaccine.  The s
Novavax Inc. NVAX shares shares sank in the extended session Tuesday after the biotech drug maker posted a wider-than-expected loss and reorganized with the appointment of a new chief executive. Novav
Novavax is expected Tuesday to report narrowing losses and strong sales fourth-quarter sales growth. Ahead of the report, NVAX stock rose.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE